Article
Brochure
Insight Hub
Executive Resource
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
Weaver has developed carbon accounting processes to determine our carbon footprint across Scope 1 and Scope 2 emissions.
Microsoft has reformed the calculation of its supply-chain emissions through innovative accounting to align with its carbon-negative 2030 goals. Learn more here.
CEOs can leverage established ESG principles and best practices to create sustainable business operations and promote long-term growth.
Weaver conducted an ESG materiality assessment survey to involve stakeholders in a quantitative assessment of ESG topics and to develop our approach.
The energy sector has been marked by its market volatility lately. CEOs in the industry can use established ESG principles to create sustainable business practices.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.
The initial enthusiasm for ESG in financial services was met with increased scrutiny, but the underlying ESG principles continue to hold sway.
California extends the deadline to develop climate reporting regulations but maintains the 2026 reporting date for scope 1 and scope 2 emissions and climate risks.
Executive ResourceBoards and management may want to consider how recent Fed activity, election uncertainty, and emerging ERP considerations will affect their businesses.
Download Weaver's ESG Report to learn about our commitment to operating openly, ethically and transparently as a firm that is focused on the future.